units
BMS3021
Faculty of Medicine, Nursing and Health Sciences
This unit entry is for students who completed this unit in 2014 only. For students planning to study the unit, please refer to the unit indexes in the the current edition of the Handbook. If you have any queries contact the managing faculty for your course or area of study.
Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.
Level | Undergraduate |
Faculty | Faculty of Medicine, Nursing and Health Sciences |
Organisational Unit | School of Biomedical Sciences |
Offered | Clayton First semester 2014 (Day) |
Coordinator(s) | Professor Robert Pike |
This unit will provide an introduction into the molecular mechanisms that mediate human diseases and the specific biotechnologies used to facilitate diagnosis and treatment. The disease mechanisms mediated by genetic disorders resulting in abnormalities in protein folding, protein trafficking and gain or loss of protein function will be presented. State of the art developments in molecular medicine including transgenic models of human disease, gene therapy, and recent developments in transplantation will be highlighted. Specific biotechnologies to be discussed include structure-based drug design, production of recombinant proteins, vaccine technology and research commercialization.
Upon completion of this unit, students will be able to:
Mid semester examination (50 minutes) (10%)
Final Examination (3 hours) (54%)
Small group activity modules (36%)
3 lectures per week and 3 hours small group activities per week.
BMS2042 and one of BCH2022 or BMS2021
(Note for Biotechnology students: Students only need to pass BCH2022)
Must be enrolled in one of the following:
+ Bachelor of Biomedical Science (including double degree programs)
+ Bachelor of Biomedical Science (Scholar Program)
+ Bachelor of Biomedical Science Advanced with Honours
+ Bachelor of Biotechnology